Showing results (121-130 of 129) with videos related to
Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 129 results.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 14, 2019
Effects of Fecal Microbiota Transplantation With Oral Capsules in Obese PatientsJessica R Allegretti, Zain Kassam, Benjamin H Mullish, et al.Plos One|March 31, 2011
Metabolites of purine nucleoside phosphorylase (NP) in serum have the potential to delineate pancreatic adenocarcinomaShaiju K Vareed, Vadiraja B Bhat, Christopher Thompson, et al.British Journal of Pharmacology|November 7, 2019
A new mechanism for cannabidiol in regulating the one-carbon cycle and methionine levels in Dictyostelium and in mammalian epilepsy modelsChristopher J Perry, Paul Finch, Annette Müller-Taubenberger, et al.Cambridge Prisms. Precision Medicine|November 27, 2025
Accelerating eSource scale-up in oncology clinical trials: The i~HD Task Force initiativeChristophe Maes, Dipak Kalra, Tracy Acito, et al.Structural Heart : the Journal of the Heart Team|March 26, 2026
Automated Referral Prompts Reveal Lack of Equitable Access to Care in Patients With Aortic StenosisSophie Offen, Sarah Johns, Terra Boone, et al.Shock (Augusta, Ga.)|December 11, 2012
Tranexamic acid and trauma: current status and knowledge gaps with recommended research prioritiesAnthony E Pusateri, Richard B Weiskopf, Vikhyat Bebarta, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 7, 2024
Multi-centre evaluation of variation in cumulative dose assessment in reirradiation scenariosNicholas Hardcastle, Eliana Vasquez Osorio, Andrew Jackson, et al.Journal of Medicinal Chemistry|July 16, 2020
Discovery and Characterization of Clinical Candidate LXE408 as a Kinetoplastid-Selective Proteasome Inhibitor for the Treatment of LeishmaniasesAdvait Nagle, Agnes Biggart, Celine Be, et al.Journal of Medicinal Chemistry|March 1, 2022
Discovery and Preclinical Pharmacology of INE963, a Potent and Fast-Acting Blood-Stage Antimalarial with a High Barrier to Resistance and Potential for Single-Dose Cures in Uncomplicated MalariaBenjamin R Taft, Fumiaki Yokokawa, Tom Kirrane, et al.Pageof 13